Quote:
Originally Posted by 'Hamas' Jenkins
There's a lot of unspecified information behind that data. Remember that this is a press release and not a clinical trial. A relative risk reduction of 84% (which is a composite endpoint--both hospitalization and ER visit) is highly unlikely to have a p-value of 0.049. If it drove down hospitalizations that much, the p-value should be much lower, in line with what they list in viral clearance and symptom changes.
|
I should have prefaced my statement with what you said. Science by press release is not really my go to, but I'm optimistic.